Skip to main content
Top
Published in: BMC Cancer 1/2009

Open Access 01-12-2009 | Research article

The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells

Authors: Jee-Youn Kim, Yong-Jun Kim, Sun Lee, Jae-Hoon Park

Published in: BMC Cancer | Issue 1/2009

Login to get access

Abstract

Background

The rapid growth of tumor parenchyma leads to chronic hypoxia that can result in the selection of cancer cells with a more aggressive behavior and death-resistant potential to survive and proliferate. Thus, identifying the key molecules and molecular mechanisms responsible for the phenotypic changes associated with chronic hypoxia has valuable implications for the development of a therapeutic modality. The aim of this study was to identify the molecular basis of the phenotypic changes triggered by chronic repeated hypoxia.

Methods

Hypoxia-resistant T98G (HRT98G) cells were selected by repeated exposure to hypoxia and reoxygenation. Cell death rate was determined by the trypan blue exclusion method and protein expression levels were examined by western blot analysis. The invasive phenotype of the tumor cells was determined by the Matrigel invasion assay. Immunohistochemistry was performed to analyze the expression of proteins in the brain tumor samples. The Student T-test and Pearson Chi-Square test was used for statistical analyses.

Results

We demonstrate that chronic repeated hypoxic exposures cause T98G cells to survive low oxygen tension. As compared with parent cells, hypoxia-selected T98G cells not only express higher levels of anti-apoptotic proteins such as Bcl-2, Bcl-XL, and phosphorylated ERK, but they also have a more invasive potential in Matrigel invasion chambers. Activation or suppression of ERK pathways with a specific activator or inhibitor, respectively, indicates that ERK is a key molecule responsible for death resistance under hypoxic conditions and a more invasive phenotype. Finally, we show that the activation of ERK is more prominent in malignant glioblastomas exposed to hypoxia than in low grade astrocytic glial tumors.

Conclusion

Our study suggests that activation of ERK plays a pivotal role in death resistance under chronic hypoxia and phenotypic changes related to the invasive phenotype of HRT98G cells compared to parent cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Maxwell PH, Pugh CW, Ratcliffe PJ: Activation of the HIF pathway in cancer. Curr Opin Genet Dev. 2001, 11: 293-299. 10.1016/S0959-437X(00)00193-3.CrossRefPubMed Maxwell PH, Pugh CW, Ratcliffe PJ: Activation of the HIF pathway in cancer. Curr Opin Genet Dev. 2001, 11: 293-299. 10.1016/S0959-437X(00)00193-3.CrossRefPubMed
2.
go back to reference Harris AL: Hypoxia: a key regulatory factor in tumour growth. Nat Rev Cancer. 2002, 2: 38-47. 10.1038/nrc704.CrossRefPubMed Harris AL: Hypoxia: a key regulatory factor in tumour growth. Nat Rev Cancer. 2002, 2: 38-47. 10.1038/nrc704.CrossRefPubMed
3.
go back to reference Alqawi O, Wang HP, Espiritu M, Singh G: Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells. Free Radic Res. 2007, 41: 788-797. 10.1080/10715760701361531.CrossRefPubMed Alqawi O, Wang HP, Espiritu M, Singh G: Chronic hypoxia promotes an aggressive phenotype in rat prostate cancer cells. Free Radic Res. 2007, 41: 788-797. 10.1080/10715760701361531.CrossRefPubMed
4.
go back to reference Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM: Serine/threonine protein kinases and apoptosis. Exp Cell Res. 2000, 256: 34-41. 10.1006/excr.2000.4836.CrossRefPubMed Cross TG, Scheel-Toellner D, Henriquez NV, Deacon E, Salmon M, Lord JM: Serine/threonine protein kinases and apoptosis. Exp Cell Res. 2000, 256: 34-41. 10.1006/excr.2000.4836.CrossRefPubMed
5.
go back to reference Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001, 22: 153-183. 10.1210/er.22.2.153.PubMed Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH: Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev. 2001, 22: 153-183. 10.1210/er.22.2.153.PubMed
6.
go back to reference Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995, 270: 1326-1331. 10.1126/science.270.5240.1326.CrossRefPubMed Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science. 1995, 270: 1326-1331. 10.1126/science.270.5240.1326.CrossRefPubMed
7.
go back to reference Cobb MH: MAP kinase pathways. Prog Biophys Mol Biol. 1999, 71: 479-500. 10.1016/S0079-6107(98)00056-X.CrossRefPubMed Cobb MH: MAP kinase pathways. Prog Biophys Mol Biol. 1999, 71: 479-500. 10.1016/S0079-6107(98)00056-X.CrossRefPubMed
8.
go back to reference Denko N, Schindler C, Koong A, Laderoute K, Green C, Giaccia A: Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin Cancer Res. 2000, 6: 480-487.PubMed Denko N, Schindler C, Koong A, Laderoute K, Green C, Giaccia A: Epigenetic regulation of gene expression in cervical cancer cells by the tumor microenvironment. Clin Cancer Res. 2000, 6: 480-487.PubMed
9.
go back to reference Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, Evans S, Ibrahim H, Le QT, Terris DJ, Giaccia AJ: Candidate genes for the hypoxic tumor phenotype. Cancer Res. 2000, 60: 883-887.PubMed Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, Evans S, Ibrahim H, Le QT, Terris DJ, Giaccia AJ: Candidate genes for the hypoxic tumor phenotype. Cancer Res. 2000, 60: 883-887.PubMed
10.
go back to reference Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, Kogel van der AJ, Riggins GT: Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst. 2001, 93: 1337-1343. 10.1093/jnci/93.17.1337.CrossRefPubMed Lal A, Peters H, St Croix B, Haroon ZA, Dewhirst MW, Strausberg RL, Kaanders JH, Kogel van der AJ, Riggins GT: Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst. 2001, 93: 1337-1343. 10.1093/jnci/93.17.1337.CrossRefPubMed
11.
go back to reference Lee MJ, Kim JY, Suk K, Park JH: Identification of the hypoxia-inducible factor 1 alpha-responsive HGTD-P gene as a mediator in the mitochondrial apoptotic pathway. Mol Cell Biol. 2004, 24: 3918-3927. 10.1128/MCB.24.9.3918-3927.2004.CrossRefPubMedPubMedCentral Lee MJ, Kim JY, Suk K, Park JH: Identification of the hypoxia-inducible factor 1 alpha-responsive HGTD-P gene as a mediator in the mitochondrial apoptotic pathway. Mol Cell Biol. 2004, 24: 3918-3927. 10.1128/MCB.24.9.3918-3927.2004.CrossRefPubMedPubMedCentral
12.
go back to reference An HJ, Maeng O, Kang KH, Lee JO, Kim YS, Paik SG, Lee H: Activation of Ras up-regulates pro-apoptotic BNIP3 in nitric oxide-induced cell death. J Biol Chem. 2006, 281: 33939-33948. 10.1074/jbc.M605819200.CrossRefPubMed An HJ, Maeng O, Kang KH, Lee JO, Kim YS, Paik SG, Lee H: Activation of Ras up-regulates pro-apoptotic BNIP3 in nitric oxide-induced cell death. J Biol Chem. 2006, 281: 33939-33948. 10.1074/jbc.M605819200.CrossRefPubMed
13.
go back to reference Friday BB, Adjei AA: Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy. Clin Cancer Res. 2008, 14: 342-346. 10.1158/1078-0432.CCR-07-4790.CrossRefPubMed Friday BB, Adjei AA: Advances in targeting the Ras/Raf/MEK/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy. Clin Cancer Res. 2008, 14: 342-346. 10.1158/1078-0432.CCR-07-4790.CrossRefPubMed
14.
go back to reference Budisavljevic MN, Hodge L, Barber K, Fulmer JR, Durazo-Arvizu RA, Self SE, Kuhlmann M, Raymond JR, Greene EL: Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis. Am J Physiol Renal Physiol. 2003, 285: F1138-1148.CrossRefPubMed Budisavljevic MN, Hodge L, Barber K, Fulmer JR, Durazo-Arvizu RA, Self SE, Kuhlmann M, Raymond JR, Greene EL: Oxidative stress in the pathogenesis of experimental mesangial proliferative glomerulonephritis. Am J Physiol Renal Physiol. 2003, 285: F1138-1148.CrossRefPubMed
15.
go back to reference Pardo OE, Arcaro A, Salerno G, Raguz S, Downward J, Seckl MJ: Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis. J Biol Chem. 2002, 277: 12040-12046. 10.1074/jbc.M109006200.CrossRefPubMed Pardo OE, Arcaro A, Salerno G, Raguz S, Downward J, Seckl MJ: Fibroblast growth factor-2 induces translational regulation of Bcl-XL and Bcl-2 via a MEK-dependent pathway: correlation with resistance to etoposide-induced apoptosis. J Biol Chem. 2002, 277: 12040-12046. 10.1074/jbc.M109006200.CrossRefPubMed
16.
go back to reference Chow S, Patel H, Hedley DW: Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry. 2001, 46: 72-78. 10.1002/cyto.1067.CrossRefPubMed Chow S, Patel H, Hedley DW: Measurement of MAP kinase activation by flow cytometry using phospho-specific antibodies to MEK and ERK: potential for pharmacodynamic monitoring of signal transduction inhibitors. Cytometry. 2001, 46: 72-78. 10.1002/cyto.1067.CrossRefPubMed
17.
go back to reference Griscelli F, Li H, Cheong C, Opolon P, Bennaceur-Griscelli A, Vassal G, Soria J, Soria C, Lu H, Perricaudet M, Yeh P: Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proc Natl Acad Sci USA. 2000, 97: 6698-6703. 10.1073/pnas.110134297.CrossRefPubMedPubMedCentral Griscelli F, Li H, Cheong C, Opolon P, Bennaceur-Griscelli A, Vassal G, Soria J, Soria C, Lu H, Perricaudet M, Yeh P: Combined effects of radiotherapy and angiostatin gene therapy in glioma tumor model. Proc Natl Acad Sci USA. 2000, 97: 6698-6703. 10.1073/pnas.110134297.CrossRefPubMedPubMedCentral
18.
go back to reference Amberger VR, Hensel T, Ogata N, Schwab ME: Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res. 1998, 58: 149-158.PubMed Amberger VR, Hensel T, Ogata N, Schwab ME: Spreading and migration of human glioma and rat C6 cells on central nervous system myelin in vitro is correlated with tumor malignancy and involves a metalloproteolytic activity. Cancer Res. 1998, 58: 149-158.PubMed
19.
go back to reference Dong Z, Wang J: Hypoxia selection of death-resistant cells. A role for Bcl-X(L). J Biol Chem. 2004, 279: 9215-9221. 10.1074/jbc.M312225200.CrossRefPubMed Dong Z, Wang J: Hypoxia selection of death-resistant cells. A role for Bcl-X(L). J Biol Chem. 2004, 279: 9215-9221. 10.1074/jbc.M312225200.CrossRefPubMed
20.
go back to reference Krzeminski P: Modulation of ERK1/2 activity in crucial for sphingosine-induced death of glioma C6 cells. Acta Biochim Pol. 2005, 52: 927-930.PubMed Krzeminski P: Modulation of ERK1/2 activity in crucial for sphingosine-induced death of glioma C6 cells. Acta Biochim Pol. 2005, 52: 927-930.PubMed
21.
go back to reference Lobner D, Liot G: Role of MAPK/ERK in neurotrophin-4 potentiation of necrotic neuronal death. Neurochem Res. 2004, 29: 2303-2309. 10.1007/s11064-004-7040-4.CrossRefPubMed Lobner D, Liot G: Role of MAPK/ERK in neurotrophin-4 potentiation of necrotic neuronal death. Neurochem Res. 2004, 29: 2303-2309. 10.1007/s11064-004-7040-4.CrossRefPubMed
22.
go back to reference Jackson RM: Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 2002, 282: C227-C241.CrossRefPubMed Jackson RM: Reactive species mechanisms of cellular hypoxia-reoxygenation injury. Am J Physiol Cell Physiol. 2002, 282: C227-C241.CrossRefPubMed
23.
go back to reference Sung SM, Jung DS, Kwon CH, Park JY, Kang SK, Kim YK: Hypoxia/reoxygenation stimulates proliferation through PKC-dependent activation of ERK and Akt in mouse neural progenitor cells. Neurochem Res. 2007, 32: 1932-1939. 10.1007/s11064-007-9390-1.CrossRefPubMed Sung SM, Jung DS, Kwon CH, Park JY, Kang SK, Kim YK: Hypoxia/reoxygenation stimulates proliferation through PKC-dependent activation of ERK and Akt in mouse neural progenitor cells. Neurochem Res. 2007, 32: 1932-1939. 10.1007/s11064-007-9390-1.CrossRefPubMed
24.
go back to reference Wang JA, Chen TL, Jiang J, Shi H, Gui C, Luo RH, Xie XJ, Xiang MX, Zhang X: Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin. 2008, 29: 74-82.CrossRefPubMed Wang JA, Chen TL, Jiang J, Shi H, Gui C, Luo RH, Xie XJ, Xiang MX, Zhang X: Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells. Acta Pharmacol Sin. 2008, 29: 74-82.CrossRefPubMed
25.
go back to reference Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK: Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008, 68: 1777-1785. 10.1158/0008-5472.CAN-07-5259.CrossRefPubMed Kumar B, Koul S, Khandrika L, Meacham RB, Koul HK: Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotype. Cancer Res. 2008, 68: 1777-1785. 10.1158/0008-5472.CAN-07-5259.CrossRefPubMed
26.
go back to reference Louis DN, Ohgaki H, Wiestler OD, Cavenee WK: WHO Classification of tumours of the central nervous system. IARC Lyon. 2007 Louis DN, Ohgaki H, Wiestler OD, Cavenee WK: WHO Classification of tumours of the central nervous system. IARC Lyon. 2007
27.
go back to reference Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114: 97-109. 10.1007/s00401-007-0243-4.CrossRefPubMedPubMedCentral Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007, 114: 97-109. 10.1007/s00401-007-0243-4.CrossRefPubMedPubMedCentral
Metadata
Title
The critical role of ERK in death resistance and invasiveness of hypoxia-selected glioblastoma cells
Authors
Jee-Youn Kim
Yong-Jun Kim
Sun Lee
Jae-Hoon Park
Publication date
01-12-2009
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2009
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-9-27

Other articles of this Issue 1/2009

BMC Cancer 1/2009 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine